These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 35709617)
21. Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma. Souza VG; Santos DJS; Silva AG; Ribeiro RIMA; Loyola AM; Cardoso SV; Miranda CSS; Cardoso LPV J Appl Oral Sci; 2022; 30():e20210344. PubMed ID: 35195152 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Diana A; Wang LM; D'Costa Z; Allen P; Azad A; Silva MA; Soonawalla Z; Liu S; McKenna WG; Muschel RJ; Fokas E Oncotarget; 2016 Jul; 7(27):40992-41004. PubMed ID: 27329602 [TBL] [Abstract][Full Text] [Related]
23. Difference in immunohistochemical findings among anti-PD-L1 antibodies and their relationships with CD4+ and CD8+ T cells in Japanese melanoma patients. Yoneta D; Kato J; Kamiya T; Horimoto K; Sato S; Sawada M; Minowa T; Hida T; Sugita S; Uhara H Int J Clin Oncol; 2022 Aug; 27(8):1364-1371. PubMed ID: 35650364 [TBL] [Abstract][Full Text] [Related]
24. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview. Ferrara G; Gianotti R; Cavicchini S; Salviato T; Zalaudek I; Argenziano G Dermatol Clin; 2013 Oct; 31(4):589-98, viii. PubMed ID: 24075547 [TBL] [Abstract][Full Text] [Related]
25. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions. Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296 [TBL] [Abstract][Full Text] [Related]
26. Nodular primary cutaneous melanoma is associated with PD-L1 expression. Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Rodig S; Mihm M; Festa Neto C; Duncan LM; Kalil J Eur J Dermatol; 2020 Aug; 30(4):352-357. PubMed ID: 32969795 [TBL] [Abstract][Full Text] [Related]
27. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features. Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786 [TBL] [Abstract][Full Text] [Related]
28. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome. Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752 [TBL] [Abstract][Full Text] [Related]
29. Copy number variations and clinical outcome in atypical spitz tumors. Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245 [TBL] [Abstract][Full Text] [Related]
30. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma. Uryvaev A; Passhak M; Hershkovits D; Sabo E; Bar-Sela G Med Oncol; 2018 Jan; 35(3):25. PubMed ID: 29388007 [TBL] [Abstract][Full Text] [Related]
31. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Taube JM; Anders RA; Young GD; Xu H; Sharma R; McMiller TL; Chen S; Klein AP; Pardoll DM; Topalian SL; Chen L Sci Transl Med; 2012 Mar; 4(127):127ra37. PubMed ID: 22461641 [TBL] [Abstract][Full Text] [Related]
32. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies. Zhao J; Meisel J; Guo Y; Nahta R; Hsieh KL; Peng L; Wei Z; O'Regan R; Li X Breast Cancer Res Treat; 2020 Oct; 183(3):599-606. PubMed ID: 32715443 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological correlation of PD-L1 and TET1 expression with tumor-infiltrating lymphocytes in non-small cell lung cancer. Ahn H; Lee HJ; Lee JH; Cho HD; Oh MH; Son JW; Jang SH Pathol Res Pract; 2020 Nov; 216(11):153188. PubMed ID: 32919305 [TBL] [Abstract][Full Text] [Related]
35. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms. Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677 [TBL] [Abstract][Full Text] [Related]
37. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer. Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749 [TBL] [Abstract][Full Text] [Related]
38. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Gill M; Cohen J; Renwick N; Mones JM; Silvers DN; Celebi JT Cancer; 2004 Dec; 101(11):2636-40. PubMed ID: 15503312 [TBL] [Abstract][Full Text] [Related]
39. Spitz nevus and atypical spitzoid neoplasm. Miteva M; Lazova R Semin Cutan Med Surg; 2010 Sep; 29(3):165-73. PubMed ID: 21051010 [TBL] [Abstract][Full Text] [Related]
40. Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC). Farrag MS; Abdelwahab K; Farrag NS; Elrefaie WE; Emarah Z J Egypt Natl Canc Inst; 2021 Jul; 33(1):16. PubMed ID: 34241710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]